Technical Analysis for MYNZ - Mainz Biomed B.V.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.23 | -7.31% | -0.02 |
MYNZ closed down 7.31 percent on Friday, November 1, 2024, on 1.46 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 11
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Wide Bands | Range Expansion | -7.31% | |
| Oversold Stochastic | Weakness | -7.31% | |
| Stochastic Buy Signal | Bullish | -10.94% | |
| NR7 | Range Contraction | -10.94% | |
| Inside Day | Range Contraction | -10.94% |
| Alert | Time |
|---|---|
| Fell Below Lower Bollinger Band | about 20 hours ago |
| Possible NR7 | about 21 hours ago |
| 2x Volume Pace | 1 day ago |
| 1.5x Volume Pace | 1 day ago |
| 3x Volume Pace | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/11/2024
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic tests for clinical diagnostics in the area of human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, an early-stage molecular lateral-flow test; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer Clinical Medicine Medical Genetics Medical Test Pancreatic Cancer Colorectal Cancer Molecular Diagnostics Diagnostic Tests Cancer Screening Innogenetics
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer Clinical Medicine Medical Genetics Medical Test Pancreatic Cancer Colorectal Cancer Molecular Diagnostics Diagnostic Tests Cancer Screening Innogenetics
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.3923 |
| 52 Week Low | 0.1852 |
| Average Volume | 2,335,940 |
| 200-Day Moving Average | 0.63 |
| 50-Day Moving Average | 0.29 |
| 20-Day Moving Average | 0.29 |
| 10-Day Moving Average | 0.27 |
| Average True Range | 0.04 |
| RSI (14) | 38.65 |
| ADX | 12.37 |
| +DI | 15.36 |
| -DI | 20.22 |
| Chandelier Exit (Long, 3 ATRs) | 0.28 |
| Chandelier Exit (Short, 3 ATRs) | 0.34 |
| Upper Bollinger Bands | 0.36 |
| Lower Bollinger Band | 0.22 |
| Percent B (%b) | 0.04 |
| BandWidth | 46.79 |
| MACD Line | -0.01 |
| MACD Signal Line | -0.01 |
| MACD Histogram | -0.0063 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.26 | ||||
| Resistance 3 (R3) | 0.26 | 0.25 | 0.25 | ||
| Resistance 2 (R2) | 0.25 | 0.24 | 0.25 | 0.25 | |
| Resistance 1 (R1) | 0.24 | 0.24 | 0.24 | 0.24 | 0.25 |
| Pivot Point | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 |
| Support 1 (S1) | 0.22 | 0.22 | 0.21 | 0.22 | 0.20 |
| Support 2 (S2) | 0.21 | 0.22 | 0.21 | 0.20 | |
| Support 3 (S3) | 0.20 | 0.21 | 0.20 | ||
| Support 4 (S4) | 0.20 |
